Urea derivatives useful as calcium receptor modulators

Details for Australian Patent Application No. 2006316705 (hide)

Owner Galapagos SAS

Inventors Temal, Taoues; Jary, Helene; Deprez, Pierre

Agent Shelston IP

Pub. Number AU-B-2006316705

PCT Pub. Number WO2007/060026

Priority 0511940 25.11.05 FR

Filing date 31 October 2006

Wipo publication date 31 May 2007

Acceptance publication date 29 September 2011

International Classifications

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/5377 (2006.01)

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/80 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 217/22 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 231/52 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 235/14 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 235/30 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 261/20 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/060026 Priority application(s): WO2007/060026

29 September 2011 Application Accepted

  Published as AU-B-2006316705

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316706-Isoquinoline and benzo[H]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine H3 receptor

2006316672-Drawer